Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated Influenza Vaccine Microneedle Patch
NCT02438423Phase 1Completed
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Fluzone Trivalent in influenza (4 arms). Primary endpoints: Solicited Injection Site and Systemic Reactogenicity, Serious Adverse Events and 1 more. Started Jun 2015; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02438423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438423.